True product innovation is a team-driven process that combines sound science with extensive, practical industry knowledge. To make a real difference in the marketplace requires more than an effective product line; it requires a management team with practical, on-farm experience and the understanding of how the products provide real value to customers. That’s the Aptimmune Difference.
Aptimmune is led by four seasoned, highly experienced management professionals with combined expertise in animal health sales and marketing, immunology, vaccine manufacturing, regulatory compliance, and swine production.
Aaron Gilbertie, President and CEO.
Mr. Gilbertie has 15 years of swine health sales and marketing experience and is former president of Four Star Animal Health, Inc. A demonstrated industry innovator, he has extensive experience in third-party vaccine manufacturing management, market research, KAM and pipeline/portfolio management.
Federico Zuckermann, PhD, Founder and Chief Science Officer.
Dr. Zuckermann is professor of immunology at the College of Veterinary Medicine at the University of Illinois and has 25 years of experience and research of the pig’s immune system, including 12 years of PRRS research. He is author of 21 publications and articles on the immune response of swine to PRRS virus.
Steve Berger, Development Director.
Mr. Berger has 30 years of USDA-CVB regulated biologics experience in the development and manufacturing of viral and bacterial vaccines with leading animal health companies including Merial, Medgene and others. At Aptimmune, he leads the product development team and proprietary technology transfer activities.
Gary Durack, Operations Director.
Mr. Durack is a successful entrepreneur, inventor and farm owner. He founded three tech companies, include iCty (now Sony Biotechnology) which he sold to Sony Corporation in 2009 and where he remained CEO until 2012.
Board of Directors
The Aptimmune board of directors consists of 5 members that include Aaron Gilbertie, Federico Zuckermann and Gary Durack, with the addition of two highly regarded scientists.
Paul Olivo, M.D., PhD
Dr. Olivo has over twenty years of experience as an executive in the biotechlogy industry.
In 2000 Dr. Olivo was named President and CSO of Apath, LLC. He was instrumental in the effort to license the company’s key hepatitis C virus patents. He also led the development of a novel technology to develop antiviral drugs. Dr. Olivo is the former Senior Medical Director of Quidel, a medical diagnostic device company. He is Managing Director of Common Place Holdings, and presently focuses on the promotion of start-up companies in the life sciences.
Robert Easter, PhD
Dr. Easter joined the University of Illinois Department of Animal Sciences faculty, serving as a professor, research scientist, the Head of the Animal Sciences Department and later went on to serve as Dean of the College of Agriculture, Consumer and Environmental Services.
In 2006 President George W. Bush appointed Dr. Easter to the Board for International Food and Agricultural Development (BIFAD) for the U.S. Agency for International Development (USAID), and in 2007 was appointed chair of BIFAD. He is a Fellow of the American Society of Animal Science and a recipient of the society’s non-ruminant research award.
Andy Wuethrich, Key Account Manager
Andy has more than 23 years of experience in agriculture, split between animal health and grain merchandising. Prior to joining Aptimmune, he worked for several animal health companies, including Elanco Animal Health. He holds a Bachelor of Science degree in agriculture from Purdue University.
Brian Konz, Key Account Manager
Brian was a professional key account manager for Novartis/Elanco Animal Health before joining Aptimmune. For the past 11 years, he was responsible for the sales of all swine products to Elanco’s key accounts and large veterinary swine practices in the upper Midwest. He holds a bachelor’s degree from Iowa State University.
Andy Smythe, Key Account Manager
Andy has worked the past two years for Novartis/Elanco Animal Health as a senior executive sales representative. He also has account management experience with Novartis Animal Health and PIC USA. He graduated with a bachelor’s degree in pre-veterinary medicine from West Virginia University.